 |
 |
 |
|
 |
|
 |
|
 |
 |
|
 Private San Diego, CA Oncology drug development company focused on novel therapeutics for prostate and breast cancer  Private New York, NY Clinical stage anti-infective company to develop dalbavancin, a once-weekly gram positive antibiotic, including MRSA, in Phase 3  Private Peapack, NJ Emerging consumer products company  Private Durham, NC Medical device company focused on innovative techniques and tools for minimally invasive surgery |
FUND III |